The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 nears one-month high

Tue, 10th Sep 2013 11:39

Receding fears about a potential US military strike on Syria and decent data from China lifted UK stocks on Thursday morning, with the FTSE 100 rising to levels not seen in nearly a month.London's benchmark index was up 0.8% at 6,581.91 by midday; the last time it closed higher was on August 14th when it ended the day at 6,587.43.Russian Foreign Minister Sergei Lavrov yesterday urged Syria to place any chemical weapons they may have under international control in an attempt to avoid action from the States. The news that Syrian counterpart Walid Muallem apparently welcomed the proposal eased concerns over a possible Western intervention this morning, especially given that President Barack Obama said that he would put air strikes on hold if Bashar al-Assad's government follows the initiative."Stocks rallied on the back of this, as investors don't want another war on their hands, and this recommendation from the Russians could sidestep military intervention while saving face," said Market Analyst David Madden from IG.Supporting stocks further was a continuing improvement in economic data from China with the third-quarter outlook for the Asian powerhouse continuing to brighten. Industrial output, fixed-asset investment and retail sales strengthened during the month of August, with all three economic indicators rising by more than expected.Market Strategist Ishaq Siddiqi from ETX Capital said that this morning's data "indicat[es] the world's second-largest economy is finally back above its knees after a turbulent first half of 2013.""China's policymakers are attempting to transform the country's economy into one based on consumption over the current model based on spending and the macro indicators are suggesting that these measures are starting to bear fruit," he said.FTSE 100: Airlines IAG and easyJet flying highAirline groups IAG and easyJet were flying higher this morning as crude continued to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Shares in easyJet were also helped by comments from Chief Executive Carolyn McCall who said in an interview that the company will be "Europe's preferred airline in five years' time" due to its low-cost operating model.Financials were also performing well today with RBS, Standard Chartered, Aviva, Aberdeen Asset Management and Schroders among the highest risers.Leading the downside was pharma giant GlaxoSmithKline which fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Costa and Premier Inn owner Whitbread was also down after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Miners were putting in a mixed performance as increased risk appetite was offset by falling metals prices across the board. Glencore Xstrata was in demand after lifting its synergy target - following its merger - to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Precious metals groups Fresnillo and Randgold, however, were out of favour. Rolls-Royce gained after scoring a $175m contract with Asia Gas Pipeline (AGP) for services on a natural gas pipeline in Kazakhstan.Broker comments were also moving a number of blue-chip stocks this morning: Drinks giant SABMiller was on the climb this morning after HSBC upgraded the stock to 'overweight'; consumer products group Unilever was lifted by Deutsche Bank to 'buy'; and Babcock was higher after JPMorgan labelled the engineering support services company as its top pick in the sector.FTSE 250: Ashmore jumps, Oxford Instruments slumpsRecord subscriptions helped emerging markets asset manager Ashmore to drive strong net inflows into its funds in the year to June, giving the share price a boost this morning. Strong net inflows of $13.4bn led to a 22% increase in assets under management (AuM) to $77.4bn during the year, with average AuM rising 13%.Oxford Instruments was a heavy faller after saying that while growth in the order intake rate in Industrial Products and third party Service is encouraging, slowness in R&D markets in the Western economies means that the year is likely to be more second half-weighted.FTSE 100 - RiserseasyJet (EZJ) 1,335.00p +5.37%International Consolidated Airlines Group SA (CDI) (IAG) 319.50p +4.58%Standard Chartered (STAN) 1,502.00p +3.19%Royal Bank of Scotland Group (RBS) 350.80p +3.18%Aviva (AV.) 412.10p +3.08%Aberdeen Asset Management (ADN) 380.40p +3.03%British Land Co (BLND) 574.00p +2.96%Glencore Xstrata (GLEN) 330.10p +2.74%Schroders (SDR) 2,486.00p +2.64%Marks & Spencer Group (MKS) 513.00p +2.50%FTSE 100 - FallersGlaxoSmithKline (GSK) 1,590.00p -3.05%Whitbread (WTB) 3,129.00p -2.71%Fresnillo (FRES) 1,249.00p -1.58%Eurasian Natural Resources Corp. (ENRC) 222.60p -0.98%Randgold Resources Ltd. (RRS) 4,869.00p -0.92%Vodafone Group (VOD) 209.00p -0.67%BG Group (BG.) 1,213.00p -0.33%Bunzl (BNZL) 1,353.00p -0.29%BP (BP.) 443.00p -0.25%Vedanta Resources (VED) 1,189.00p -0.08%FTSE 250 - RisersOcado Group (OCDO) 374.20p +6.91%Ashmore Group (ASHM) 387.60p +6.81%Fenner (FENR) 390.40p +5.26%Thomas Cook Group (TCG) 157.50p +5.07%Inchcape (INCH) 641.00p +4.74%Ferrexpo (FXPO) 186.60p +4.42%Laird (LRD) 233.30p +4.34%Galliford Try (GFRD) 1,066.00p +4.20%Berendsen (BRSN) 940.50p +3.75%Betfair Group (BET) 1,050.00p +3.55%FTSE 250 - FallersOxford Instruments (OXIG) 1,423.00p -5.76%African Barrick Gold (ABG) 175.00p -4.68%Rank Group (RNK) 155.00p -2.58%PayPoint (PAY) 1,086.00p -1.63%Moneysupermarket.com Group (MONY) 170.00p -1.33%BH Macro Ltd. EUR Shares (BHME) € 20.78 -1.28%Telecom Plus (TEP) 1,337.00p -1.26%Telecity Group (TCY) 836.50p -1.18%BH Macro Ltd. GBP Shares (BHMG) 2,140.00p -1.02%BH Global Ltd. GBP Shares (BHGG) 1,181.00p -1.01%BC
More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.